Ausnahme gefangen: SSL certificate problem: certificate is not yet valid 📌 Flickering Lights May Illuminate A Path To Alzheimer's Treatment

🏠 Team IT Security News

TSecurity.de ist eine Online-Plattform, die sich auf die Bereitstellung von Informationen,alle 15 Minuten neuste Nachrichten, Bildungsressourcen und Dienstleistungen rund um das Thema IT-Sicherheit spezialisiert hat.
Ob es sich um aktuelle Nachrichten, Fachartikel, Blogbeiträge, Webinare, Tutorials, oder Tipps & Tricks handelt, TSecurity.de bietet seinen Nutzern einen umfassenden Überblick über die wichtigsten Aspekte der IT-Sicherheit in einer sich ständig verändernden digitalen Welt.

16.12.2023 - TIP: Wer den Cookie Consent Banner akzeptiert, kann z.B. von Englisch nach Deutsch übersetzen, erst Englisch auswählen dann wieder Deutsch!

Google Android Playstore Download Button für Team IT Security



📚 Flickering Lights May Illuminate A Path To Alzheimer's Treatment


💡 Newskategorie: IT Security Nachrichten
🔗 Quelle: science.slashdot.org

Slashdot reader rpavlicek writes, "Research done by MIT late this year has shown that light signals can improve the brain's neuron gamma frequency which can reverse the effects of Alzheimer's disease (by removing brain plaque). Beneficial effects were found in both intercranial and optical stimuli." The Los Angeles Times reports: New research demonstrates that, in mice whose brains are under attack by Alzheimer's dementia, exposure to lights that flicker at a precise frequency can right the brain's faulty signaling and energize its immune cells to fight off the disease... In mice, these effects were limited to the visual cortex. In humans with Alzheimer's, that's not one of the brain regions that gets gummed up early or significantly by amyloid plaques. But the authors of the new research held out hope that the light therapy might induce gamma oscillations, or their immune-boosting effect, more broadly in human brains, or that some change in delivery of the light might extend its effects to brain regions, such as the hippocampus, that are profoundly affected by Alzheimer's. A startup has already approached the FDA seeking clinical trials, and the L.A. Times adds that "Even if the new research does not yield a treatment for Alzheimer's, it is expected to deepen understanding of a key player in the disease -- the brain's dedicated immune system -- and point to ways it can be used to fight the disease."

Read more of this story at Slashdot.

...













matomo